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Previous reports between investigating adiposity and cognitive function in the population 
allude to a negative association, although the relationship in older adults is unclear. The aim 
of this study was to investigate the association of adiposity (Body Mass Index (BMI) and 
Waist-Hip Ratio (WHR)) with cognitive function in community dwelling older adults (>60 
yrs). Participants included 5,186 adults from the Trinity, Ulster and Department of 
Agriculture aging cohort study. Neuropsychological assessment measures included the Mini-
Mental State Examination (MMSE), Frontal Assessment Battery (FAB) and Repeatable 
Battery for the Assessment of Neuropsychological Status (RBANS). Multi-variable linear 
regression models were used to assess the association between adiposity and cognitive 
function adjusting for insulin resistance, inflammation and cerebrovascular disease. The 
mean (SD) ages were 80.3(6.7), 71.0(7.3) and 70.2(6.3) years on the Cognitive, Bone and 
Hypertensive cohorts, respectively. In the Cognitive cohort, BMI was positively associated 
with immediate and delay memory, visuospatial/constructional ability, language and MMSE 
and negatively with FAB(log-transformed) whereas WHR was negatively associated with 
attention.  In the Bone cohort, BMI was not associated with any cognitive domain whereas 
WHR was negatively associated with visuospatial/constructional ability, attention and 
MMSE. In the Hypertensive cohort, BMI was not associated with any cognitive domain 
whereas WHR was negatively associated with immediate and delay memory, 
visuospatial/constructional ability, language and MMSE and positively with FAB(log-
transformed). In the Cognitive and Bone cohorts, the association of WHR and attention  
disappeared by further controlling for C-Reactive Protein and HbA1C. In this study of older 
adults, central adiposity was a stronger predictor of poor cognitive performance than BMI. 
Older adults could benefit from targeted public health strategies aimed at reducing obesity 















The number of cases of dementia is increasing in both developing and developed countries 
and is predicted to rise from 24.3 million in 2001 to 42.3 million in 2020 and again to 81.1 
million by 2040 (1). Just over one in twelve (8.1%) of people aged 65 years or over have 
dementia and 1 in five (20.6%) have cognitive impairment without dementia (CIND) (2). The 
global age-standardized prevalence of obesity  doubled from 6.4% in 1980 to 12.0% in 2008 
whilst overweight prevalence increased from 24.6% to 34.4% during the same 28-year period 
(3). 
 
In adults aged 19-65 years, cross-sectional studies suggest that the overweight perform worse 
on tests of semantic memory, visuospatial ability (4) and executive function (5-7) compared to 
normal weight participants. Prospective studies have observed lower cognitive scores and 
greater cognitive decline in obese versus normal weight participants, with fastest decline in 
those with both obesity and metabolic abnormality (8). Furthermore, a twenty-seven year 
longitudinal population based study observed that obesity in middle age increased the risk of 
future dementia independently of comorbid conditions (9). 
 
In older adults aged ≥ 65 years, the association between adiposity and cognitive function is 
less clear. The Neurological Diseases in Central Spain study (NEDICES) observed that 
obese/overweight status was associated with the lowest quartiles on cognitive testing (10). 
Other studies reported negative associations of obesity and cognitive function in those with 
mean age of 72 years (11) and less than 70 years (12) versus positive association in those with 
mean age above 73 years and those aged 70 years and over, respectively. Conversely, better 
performance was shown in overweight participants with mean age of 73 years (13) and 
overweight oldest-old (75-90 years) (4) as compared to normal weight older participants. 
Comparison between studies is problematic as most measured specific and different cognitive 
domains. 
 
The aim of this study was to determine whether adiposity, estimated by Body Mass Index 
(BMI)) and waist-hip ratio (WHR) was associated with cognitive function (as defined by 
Mini-Mental State Examination Score (MMSE), Frontal Assessment Battery (FAB) and a 
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detailed neuropsychological test battery - Repeatable Battery for the Assessment of 




The study population comprised participants from the Trinity, Ulster and Department of 
Agriculture (TUDA) ageing cohort study. This was a large study of community dwelling 
older Irish adults (>60 years) recruited between 2008 and 2012 and designed to investigate 
nutritional factors, related gene-nutrient interactions and health and lifestyle factors in the 
development of chronic diseases of aging (cardiovascular disease (CVD), osteoporosis and 
dementia). A detailed description of the study population and recruitment has been published 
previously (14-16). In short, there were three disease defined cohorts- cognitive impairment 
(Cognitive), osteopaenia/osteoporosis (Bone) and hypertension (Hypertensive). The 
Cognitive cohort (RBANS score ≤80) consisted of 1,699 participants who were recruited 
from general geriatric clinics and a day hospital at the Department of Medicine for the 
Elderly at St. James’s Hospital, Dublin. The Bone cohort consisted of 1,394 participants who 
were recruited from a specialist bone health service at the Department of Medicine for the 
Elderly at St. James’s Hospital, Dublin with a diagnosis of osteoporosis or osteopaenia 
(within three years of recruitment) as defined by standard WHO criteria (T score of ≤ -2.5 
and ≤ -1.0 to > -2.5 respectively) (17). The Hypertensive cohort consisted of 2,093 
participants who were recruited from general practices in the catchment area of the Western 
and Northern Health and Social Care Trusts in Northern Ireland with a current diagnosis of 
hypertension verified by their general practitioners. Of the 5,186 participants recruited, all 
those whose MMSE scores were less than 24 or missing were excluded (as their cognitive 
performance might bias the results) as were those with a missing BMI or WHR score leaving 
a total of 4,439 participants for this sub-study (Figure 1).  Ethical approval was granted by 
the relevant authorities in each jurisdiction: the Research Ethics Committee of St. James’s 
Hospital and The Adelaide and Meath Hospital, Dublin, and the Office for Research Ethics 
Committees Northern Ireland (ORECNI; reference 08/NI/RO3113) with corresponding 
approvals from the Northern and Western Health and Social Care Trusts, Northern Ireland. 
 
Lifestyle and anthropometric information 
Data associated with lifestyle factors were obtained by questionnaire and included sex, age, 
ethnicity, education and medical history (including medication use). Data that were recorded 
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also included current smoking and alcohol intake, falls and psychosocial history. 
Anthropometric measurements included height to the nearest 0.01 m (using a wall-mounted 
stadiometer from Seca Ltd), weight to the nearest 0.01 kg (using electronic scales from 
Brosch Direct Ltd), and waist and hip circumference to the nearest 0.1 cm (using a flexible 
tape measure from Seca Ltd). BMI was calculated as weight (kilograms) divided by height 
(meters) squared. 
 
Cognitive and physical function measures  
Cognitive assessment measures included MMSE, total FAB and RBANS. In all participants, 
MMSE(18) was performed. The FAB is a brief battery of six neuropsychological tasks 
designed to assess frontal lobe function (19). These include similarities (conceptualization), 
lexical fluency (mental flexibility), motor series “Luria” test (programming), conflicting 
instructions (sensitivity to interference), Go–No Go (inhibitory control) and prehension 
behaviour (environmental autonomy). A cut off score of 12 on the FAB has a sensitivity of 
77% and specificity of 87% in differentiating between frontal dysexecutive type dementias 
and dementia of Alzheimer type. RBANS has 5 indices and a total scale(20) as follows: Index 
I (immediate memory), index II (visuospatial/constructional ability), index III (language), 
index IV (attention) and index V (delayed memory). The Timed Up and Go (TUG) test(21) 
and the Lawton Instrumental Activities of Daily Living (IADL) Scale  (22) were used as 
measures of frailty.  
 
Statistical analyses 
The statistical analysis was performed using the Statistical Package for Social Sciences 
(version 23.0; SPSS UK Ltd.; Chersey, UK). Demographic and cognitive variables were 
illustrated by descriptive statistics, including numbers and percentages, medians, ranges, and 
mean values and standard deviations. The data were checked for normality, linear 
relationship, multivariate normality, multicollinearity, auto-correction, homoscedasticity and 
outliers and the FAB score was log transformed as it was skewed. Where appropriate, one-
way ANOVA or the Wilcoxon signed rank test was used for continuous variables while 
categorical variables were assessed by chi-square analysis. Comprehensive Meta Analysis 
(CMA) software was used to combine the results and provide a point estimate and assess 
heterogeneity. Multi-variable linear regression models were used for modelling the 
relationship between cognition and adiposity. Model 1 controlled for the covariates age, sex, 
education, frailty (TUG and IADL), current and past smoking. The data was not adjusted for 
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blood pressure as one of our cohorts consisted of patients recruited on the basis of being 
hypertensive. In order to look at potential effect modifiers, three further analyses were pre 
specified based on the understanding of how adiposity might have negative consequences on 
cognition (i.e. insulin resistance, cerebrovascular damage and inflammation). In models 2, 3 
and 4, HbA1C, cerebrovascular diseases (stroke and/or transient ischaemic attack) and c-
reactive protein (CRP), respectively were added to model 1.  
 
RESULTS 
Interaction terms were graphed between cohorts (online supplementary information, figure 
1S). There was an interaction between adiposity and cognitive tests by cohorts. Given the 
interaction we analysed the data for the whole cohorts and then treated each cohort 
separately. Cohort characteristics are presented in table 1. Participants in the Cognitive cohort 
were about 10 years older than the other 2 cohorts, and were more frail with higher TUG, 
lower IADL and lower cognitive scores, p<0.001. 
 
Table 2 summarizes the relationship between adiposity and cognitive function in all TUDA 
participants. WHR was negatively associated with cognitive function across all tests except 
FAB (log-transformed). BMI was positively associated with cognitive function across a 
number of cognitive tests except FAB (log-transformed). Tables 3, 4 and 5 details the results 
in the Cognitive, Bone and Hypertensive cohorts, respectively. 
 
WHR was negatively associated with cognitive function in all 3 cohorts but effects attenuated 
across cohorts. The effect was strongest in Hypertensive and less so in the older Cognitive 
cohort. BMI was not associated with cognitive function in the Bone and Hypertensive, but 
was positively associated in the Cognitive cohort. The associations were generally not 
attenuated by any pre-specified analysis apart from two (CRP and HbA1C) factors in the 
Bone and Cognitive cohorts for RBANS Index IV (a measure of attention) from statistically 
significant to non-significant. 
 
In the cognitive cohort, BMI was positively associated with immediate and delay memory, 
visuospatial/constructional ability, language and MMSE, and negatively with FAB 
(logtransformed), whereas WHR was negatively associated with attention. In the bone cohort, 
BMI was not associated with any cognitive domain, whereas WHR was negatively associated 
 
7 
with visuospatial/constructional ability, attention and MMSE. In the hypertensive cohort, 
BMI was not associated with any cognitive domain, whereas WHR was negatively associated 
with immediate and delayed memory, visuospatial/constructional ability, language and 
MMSE and positively with FAB (logtransformed). In the cognitive and bone cohorts, the 
association of WHR and attention disappeared by further controlling for Creactive 
protein and HbA1C. 
 
On meta-analysis, using the three cohorts, BMI was not statistically significantly associated 
with cognitive function on all RBANS subsets, MMSE or FAB(log) (online supplementary 
table S1). However, WHR was statistically associated with cognitive function on all RBANS 
subsets, MMSE and FAB(log). There was an attenuation of results from statistically 
significant to non-significant on adjusting for CRP in RBANS index II only (supplementary 
table S2). Furthermore, there was a statistically significant heterogeneity between BMI and 
cognitive function on RBANS Index I, III, V, total scale and FAB(log) on model 1, 2,3 and 4 
with further heterogeneity on MMSE in model 2 and model 4. There was a significant 




This large observational study showed that was associated with poorer cognitive function in 
older people. We found significant and robust negative associations between a measure of 
central adiposity and multiple domains of cognition. In contrast, however, after adjusting for 
central adiposity, BMI was only associated with cognition in the oldest (cognitively 
impaired) cohort and that association was positive. Some associations were explained by 
markers of inflammation or insulin resistance. This supports that the relationship between 
obesity and cognition is complex and that central (rather than general) adiposity is the main 
driver. 
 
Our results on the association between central adiposity, measured by WHR, and cognitive 
function are comparable to other studies. Dore et al.(6) reported that waist circumference and 
waist/hip ratio were inversely related to cognitive function using the Wechsler Adult 
Intelligence Scale, the Halstead-Reitan Neuropsychological Battery, the Wechsler Memory 
Scale Revised, and the MMSE in adults with mean (SD) age of 62.0 (12.8) years even though 
the relationship was attenuated by adjusting for physical activity level. A study of 250 
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participants using MMSE reported that high adiposity, particularly central adiposity, was 
associated with poor cognitive performance in subjects younger than 70 years, but not in 
those aged 70 years and over (12). A large elderly population study (aged 60 years and over, 
with mean age of 70.6 years) using a Chinese version of the Mini-Mental State Examination 
reported that a higher waist circumference (WC) and WHR were associated with an increased 
prevalence of cognitive impairment (23). 
 
In our study, BMI was positively associated with MMSE in the Cognitive Cohort but no 
association was found in other cohorts. Moreover, total obesity (measured by BMI) had been 
found to have an insignificant effect on cognitive impairment (23). The Neurological Diseases 
in Central Spain study (NEDICES) suggested that obese/overweight status, using BMI, was 
associated with the lowest quartiles of the 37-MMSE, Trail Making Test-A (number of 
errors; indeed more errors), verbal fluency, delayed free recall, immediate logical memory 
and pre-morbid intelligence (10). In contrast, in our Cognitive Cohort, BMI was positively 
associated with immediate and delay memory, visuospatial/constructional abilities and 
language. The contrasting results could be explained by the fact that we controlled for BMI 
and WHR rather than BMI alone. 
 
Nilson and Nilson (4) examining the oldest old (75-90 years) reported that overweight (BMI) 
subjects performed significantly better on visuospatial ability than those with normal weight. 
This is further supported by a study of 2 684 individuals aged 65-94 years with mean age of 
73 years that showed overweight (BMI) subjects had better performance in terms of 
reasoning and visuospatial speed of processing than normal-weight participants (13). The 
Cardiovascular Health Study (24), mean age over 73 years, revealed that high adiposity (WC 
and BMI) and high fat-free mass in the elderly were related to slower cognitive decline 
measured with the modified MMSE, the Digit Symbol Substitution Test, and a composite of 
both. 
 
BMI measures total adiposity whereas WC and WHR measure central adiposity. Whether 
BMI is a good measure of adiposity in older people is unclear owing to the fact that weight 
does not differentiate between fat and fat-free mass and unreliable measures of height due to 
shrinkage and vertebral collapse (25). A large study of subjects aged 75 years and over (n = 14 
833) in the UK reported an inverse association of BMI with mortality in women and no 
association in men, with WHR being positively related to circulatory mortality in both men 
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and women (25). Moreover, Hermsdorff et al. (26) found that central adiposity-related 
indicators (WC/WHR) correlated better than those assessing total adiposity with plasma 
proinflammatory markers. 
 
In the Cognitive and Bone cohorts, WHR and attention (digit span and coding) association 
disappeared by further controlling for HbA1C. HbA1C was used as a surrogate marker for 
diabetes mellitus/insulin resistance. Our results suggest that insulin resistance may modify 
the association between cognitive function and WHR. Abbatecola et al. (28)reported that total 
fat mass and central adiposity (WC and WHR) predicted an increased risk for cognitive 
decline in older person with diabetes (28). The proposed mechanism of cognitive decline in 
diabetes is through hippocampal insulin resistance in addition to or separate from 
inflammation. 
 
The association between WHR and attention disappeared by further controlling for CRP in 
the Bone and Cognitive cohorts. This implies that inflammation may have a role in 
explaining attention deficits. Obesity is a proinflammatory state with elevated levels of 
cytokines including TNF-α, interleukin 6 (IL-6) (29). Investigation of systemic markers of 
inflammation revealed that higher levels of CRP and IL-6 were cross-sectionally associated 
with worse global cognition and executive function in the Rotterdam Study while only IL-6 
in the Leiden 85-plus Study (30). Furthermore, plasma levels of inflammatory proteins are 
reported to be increased before clinical onset of dementia (31). 
 
Even though cerebrovascular diseases did not attenuate the relationship between adiposity 
and cognitive function on analysis in our study, it is known to affect cognitive function. 
Obesity is a known vascular risk factor that predisposes individuals to Alzheimer’s disease 
and vascular dementia(32). The postulated mechanism is through blood-brain barrier 
dysfunction leading to hypoperfusion and as a result increased accumulation of ß-amyloid(32). 
Blood-brain barrier dysfunction is associated with both Alzheimer's disease and vascular 
dementia among very elderly individuals (33). Our failure to detect an attenuation could be due 
to the small number of participants with cerebrovascular disease in the current study or the 
fact that subjects with dementia were excluded. Alternatively cerebrovascular disease may 





The association between adiposity and cognitive function was not attenuated by any 
prespecified analyses in the hypertensive group. Perhaps there was no attenuation due to the 
fact that hypertension itself is associated with inflammation. Hypertension is associated with 
insulin resistance (34) and inflammation, with CRP being the inflammatory marker with the 
strongest association (35). Singer et al. (36)using the original cohort of the Framingham Heart 
Study reported that HbA1C was associated with hypertension. Furthermore, the ATTICA 
study revealed an association between prehypertension and inflammatory markers linked to 
the atherosclerotic process including CRP (37). 
 
The major strengths of this study include the study size, the well characterized population and 
a comprehensive battery of cognitive tests. We used a full neuropsychological test battery -
RBANS to measure specific cognitive performances ie attention, language, 
visuospatial/constructional abilities, and immediate and delayed memory and analyse them 
individually unlike other studies. Additionally, the statistical analysis was able to adjust for a 
wide range of confounders and covariates not usually recorded. There are some limitations; 
this is a cross-sectional study and hence cannot explain causal relationship. In particular we 
cannot exclude reverse causation. Singh-Manoux et al. (38) reported either an attenuated or 
reversed risk of dementia associated with obesity at older ages. 
It was not possible to adjust for physical activity even though it has been previously shown to 
have a positive impact on cognitive function while bio impedance tests were unavailable to 
accurately assess the true scale of the adiposity. 
 
In conclusion, this is one of the largest studies of older adults to demonstrate that central 
adiposity is associated with subtle cognitive impairment in community dwelling older adults. 
Given the high prevalence of overweight and obesity in the older population and the 
economic and social burden of cognitive dysfunction, reducing  obesity and exposure to 
obesogenic risk factors could be a cost effective and effective public health strategy for the 
prevention of dementia and cognitive impairment in older adults.  
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Figure 1: The Trinity Ulster Department of Agriculture (TUDA) Study Population.  
*missing or incomplete data 
 
Figure 1S: Interaction between TUDA cohorts. All figures show an interaction between 


































Table 2: Adiposity versus Cognitive function in TUDA Cohorts (N=4439) 
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 Model 1 Model 2 Model 3 Model 4 
Cognitive Test (SE) P-value (SE) P-value (SE) P-value (SE) P-value 
RBANS Index I                      R2=0.163                  R2=0.170                     R2=0.164                     R2=0.168 
BMI 0.060(0.048) 0.210 0.069(0.049) 0.165 0.059(0.048) 0.217 0.045(0.049) 0.358 
WHR -19.318(3.410) <0.001 -18.654(3.488) <0.001 -19.265(3.409) <0.001 -18.101(3.456) <0.001 
RBANS Index II                     R2=0.241                  R2=0.248                     R2=0.243         R2=0.217 
BMI 0.127(0.060) 0.017 0.129(0.055) 0.019 0.125(0.053) 0.019 0.128(0.055) 0.019 
WHR -14.261(4.212) <0.001 -13.938(3.883) <0.001 -14.125(3.785) <0.001 -16.388(3.866) <0.001 
RBANS Index III                      R2=0.156                  R2=0.165                     R2=0.157          R2=0.161 
BMI 0.196(0.035) <0.001 0.218(0.036) <0.001 0.195(0.035) <0.001 0.203(0.035) <0.001 
WHR -7.544(2.475) 0.002 -7.511(2.516) 0.003 -7.508(2.474) 0.002 -7.086(2.511) 0.005 
RBANS Index IV                      R2=0.249                  R2=0.256                     R2=0.252         R2=0.251 
BMI 0.043(0.048) 0.361 0.059(0.049) 0.225 0.041(0.048) 0.386 0.047(0.048) 0.332 
WHR -8.338(3.374) 0.013 -7.182(3.456) 0.038 -8.179(3.369) 0.015 -8.079(3.431) 0.019 
RBANS Index V                      R2=0.149                  R2=0.150                     R2=0.149          R2=0.151 
BMI 0.133(0.050) 0.008 0.130(0.052) 0.012 0.133(0.050) 0.008 0.125(0.051) 0.014 
WHR -16.899(3.540) <0.001 -18.365(3.642) <0.001 -16.867(3.540) <0.001 -15.897(3.606) <0.001 
RBANS Total Scale                     R2= 0.300                  R2=0.308                     R2=0.301          R2=0.303 
BMI 0.126(0.042) 0.003 0.139(0.043) 0.001 0.124(0.042) 0.003 0.117(0.043) 0.006 
WHR -17.201(2.988) <0.001 -17.070(3.055) <0.001 -17.081(2.985) <0.001 -16.332(3.038) <0.001 
MMSE                      R2=0.172                  R2=0.176                     R2=0.173                     R2=0.173 
BMI 0.005(0.005) 0.304 0.004(0.005) 0.401 0.005(0.005) 0.314 0.004(0.005) 0.460 
WHR -1.264(0.333) <0.001 -1.293(0.342) <0.001 -1.259(0.333) <0.001 -1.153(0.339) 0.001 
FAB(log)                      R2=0.166                  R2=0.169                     R2=0.166                      R2=0.164 
BMI -0.002(0.001) 0.063 -0.002(0.001) 0.043 -0.002(0.001) 0.064 -0.001(0.001) 0.112 
WHR 0.217(0.062) <0.001 0.203(0.063) 0.001 0.217(0.062) <0.001 0.191(0.063) 0.001 
 
 
Model 1: Age, Education (Duration schooling), Sex (male), BMI, WHR, Current smoker, Past smoker, TUG, Total IADL 
Model 2: Model 1 + Haemoglobin A1C (HbA1C) 
Model 3: Model 1 + cerebrovascular diseases(transient ischaemic attack and/or stroke) 




Abbreviations: BMI-Body Mass Index, WHR- Waist-Hip Ratio, TUG- Timed-Up-and-Go, IADL- Instrumental Activities of Daily Living, 
















Table 3: Adiposity versus Cognitive function in TUDA Cognitive Cohort  (N=1282) 
                  Model 1 Model 2 Model 3 Model 4 
Cognitive Test (SE) P-value (SE) P-value (SE) P-value (SE) P-value 
RBANS Index I                      R2=0.144                  R2=0.144                     R2=0.144                     R2=0.148 
BMI 0.349(0.084) <0.001 0.365(0.092) <0.001 0.349(0.084) <0.001 0.342(0.084) <0.001 
WHR -9.051(5.957) 0.129 -8.149(6.741) 0.227 -9.056(5.960) 0.129 -9.016(6.083) 0.139 
RBANS Index II                     R2=0.150                  R2=0.150                     R2=0.154         R2=0.150 
BMI 0.256(0.097) 0.008 0.255(0.099) 0.010 0.249(0.097) 0.010 0.240(0.098) 0.014 
WHR -0.679(6.905) 0.922 -0.425(6.944) 0.951 -0.393(6.894) 0.955 1.224(7.059) 0.862 
RBANS Index III                      R2=0.093                  R2=0.095                     R2=0.094          R2=0.099 
BMI 0.451(0.072) <0.001 0.463(0.073) <0.001 0.448(0.072) <0.001 0.447(0.072) <0.001 
WHR -7.253(5.107) 0.156 -6.611(5.132) 0.198 -7.187(5.106) 0.159 -6.772(5.212) 0.194 
RBANS Index IV                      R2=0.164                  R2=0.168                     R2=0.170         R2=0.165 
BMI 0.119(0.075) 0.113 0.141(0.077) 0.066 0.112(0.075) 0.138 0.112(0.076) 0.108 
WHR -11.469(5.353) 0.032 -10.346(5.383) 0.055 -11.099(5.338) 0.038 -10.470(5.489) 0.057 
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RBANS Index V                      R2=0.097                  R2=0.097                     R2=0.097          R2=0.103 
BMI 0.451(0.095) <0.001 0.442(0.097) <0.001 0.451(0.096) <0.001 0.467(0.096) <0.001 
WHR -11.200(6.810) 0.100 -12.359(6.841) 0.071 -11.209(6.813) 0.100 -10.678(6.944) 0.124 
RBANS Total Scale                     R2= 0.189                  R2=0.181                     R2=0.191          R2=0.194 
BMI 0.395(0.074) <0.001 0.399(0.084) <0.001 0.390(0.074) <0.001 0.392(0.075) <0.001 
WHR -10.661(5.287) 0.044 -12.050(6.085) 0.048 -10.451(5.285) 0.048 -9.516(5.397) 0.078 
MMSE                      R2=0.146                  R2=0.144                     R2=0.147                     R2=0.146 
BMI 0.021(0.009) 0.018 0.021(0.009) 0.025 0.021(0.009) 0.021 0.022(0.009) 0.016 
WHR -0.511(0.643) 0.427 -0.623(0.646) 0.335 -0.502(0.643) 0.435 -0.449(0.658) 0.495 
FAB(log)                      R2=0.181                  R2=0.178                     R2=0.182                      R2=0.178 
BMI -0.007(0.002) <0.001 -0.007(0.002) <0.001 -0.007(0.002) <0.001 -0.007(0.002) <0.001 
WHR 0.170(0.117) 0.146 0.180(0.117) 0.125 0.172(0.117) 0.142 0.149(0.120) 0.212 
 
 
Model 1: Age, Education (Duration schooling), Sex (male), BMI, WHR, Current smoker, Past smoker, TUG, Total IADL 
Model 2: Model 1 + Haemoglobin A1C (HbA1C) 
Model 3: Model 1 + cerebrovascular diseases(transient ischaemic attack and/or stroke) 
Model 4: Model 1 + c-reactive protein (CRP) 
 
Abbreviations: BMI-Body Mass Index, WHR- Waist-Hip Ratio, TUG- Timed-Up-and-Go, IADL- Instrumental Activities of Daily Living, 









Table 4: Adiposity versus Cognitive function in TUDA Bone Cohort (N=1248) 
 Model 1 Model 2 Model 3 Model 4 
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Cognitive Test (SE) P-value (SE) P-value (SE) P-value (SE) P-value 
RBANS Index I                      R2=0.121                  R2=0.148                     R2=0.125                     R2=0.139 
BMI 0.021(0.097) 0.831 0.013(0.103) 0.902 0.031(0.097) 0.753 -0.046(0.098) 0.638 
WHR -11.285(6.781) 0.096 -10.462(7.211) 0.147 -10.841(6.772) 0.110 -6.623(6.836) 0.333 
RBANS Index II                     R2=0.182                  R2=0.201                     R2=0.183         R2=0.185 
BMI 0.033(0.108) 0.762 0.007(0.115) 0.949 0.039(0.108) 0.717 0.030(0.110) 0.783 
WHR -25.456(7.524) 0.001 -28.541(8.085) <0.001 -25.152(7.523) 0.001 -26.001(7.698) 0.001 
RBANS Index III                      R2=0.071                  R2=0.093                     R2=0.072          R2=0.078 
BMI 0.013(0.071) 0.858 0.079(0.074) 0.288 0.016(0.071) 0.816 0.037(0.072) 0.611 
WHR -1.174(4.960) 0.813 -1.073(5.191) 0.836 -1.004(4.961) 0.840 -0.241(5.027) 0.962 
RBANS Index IV                      R2=0.198                  R2=0.221                     R2=0.201         R2=0.203 
BMI -0.040(0.097) 0.683 -0.012(0.104) 0.912 -0.030(0.097) 0.757 -0.049(0.100) 0.623 
WHR -14.152(6.788) 0.037 -13.827(7.288) 0.058 -13.676(6.781) 0.044 -12.871(6.943) 0.064 
RBANS Index V                      R2=0.114                  R2=0.126                     R2=0.114          R2=0.124 
BMI 0.039(0.090) 0.660 0.026(0.096) 0.787 0.042(0.090) 0.637 0.021(0.091) 0.821 
WHR -5.907(6.264) 0.346 -11.377(6.724) 0.091 -5.783(6.269) 0.356 -2.867(6.351) 0.652 
RBANS Total Scale                     R2=0.228                  R2=0.259                     R2=0.231          R2=0.239 
BMI 0.010(0.089) 0.908 0.028(0.095) 0.764 0.018(0.089) 0.840 -0.010(0.091) 0.914 
WHR -15.440(6.206) 0.013 -17.877(6.621) 0.007 -15.053(6.200) 0.015 -13.243(6.320) 0.036 
MMSE                      R2=0.154                  R2=0.160                     R2=0.155                     R2=0.156 
BMI -0.009(0.010) 0.336 -0.011(0.010) 0.285 -0.009(0.010) 0.371 -0.013(0.010) 0.202 
WHR -1.824(0.672) 0.007 -1.763(0.729) 0.016 -1.795(0.672) 0.008 -1.533(0.688) 0.026 
FAB(log)                      R2=0.149                  R2=0.167                     R2=0.155                      R2=0.144 
BMI 0.002(0.002) 0.267 0.002(0.002) 0.227 0.002(0.002) 0.325 0.002(0.002) 0.263 
WHR 0.111(.124) 0.369 0.064(0.134) 0.635 0.101(0.124) 0.415 0.092(0.128) 0.470 
 
 
Model 1: Age, Education (Duration schooling), Sex (male), BMI, WHR, Current smoker, Past smoker, TUG, Total IADL 
Model 2: Model 1 + Haemoglobin A1C (HbA1C) 
Model 3: Model 1 + cerebrovascular diseases(transient ischaemic attack and/or stroke) 




Abbreviations: BMI-Body Mass Index, WHR- Waist-Hip Ratio, TUG- Timed-Up-and-Go, IADL- Instrumental Activities of Daily Living, 












Table 5: Adiposity versus Cognitive function in TUDA Hypertensive Cohort (N=1909)  
 Model 1 Model 2 Model 3 Model 4 
Cognitive Test (SE) P-value (SE) P-value (SE) P-value (SE) P-value 
RBANS Index I                      R2=0.165                  R2=0.166                     R2=0.166                     R2=0.162 
BMI 0.110(0.077) 0.152 0.120(0.078) 0.124 0.107(0.077) 0.163 0.112(0.079) 0.152 
WHR -21.993(5.241) <0.001 -21.006(5.311) <0.001 -21.991(5.240) <0.001 -21.229(5.326) <0.001 
RBANS Index II                     R2=0.207                  R2=0.208                     R2=0.208         R2=0.210 
BMI -0.002(0.084) 0.980 0.020(0.085) 0.818 -0.005(0.084) 0.954 -0.038(0.086) 0.655 
WHR -18.552(5.750) 0.001 -17.277(5.820) 0.003 -18.533(5.749) 0.001 -18.217(5.821) 0.002 
RBANS Index III                      R2=0.141                  R2=0.140                     R2=0.141          R2=0.146 
BMI 0.079(0.048) 0.096 0.080(0.048) 0.098 0.080(0.048) 0.095 0.076(0.048) 0.117 
WHR -9.729(3.253) 0.003 -9.883(3.291) 0.003 -9.729(3.253) 0.003 -9.320(3.282) 0.005 
RBANS Index IV                      R2=0.158                  R2=0.158                     R2=0.159         R2=0.156 
BMI 0.038(0.080) 0.632 0.049(0.081) 0.545 0.036(0.080) 0.650 0.052(0.081) 0.525 
WHR -3.451(5.465) 0.528 -2.180(5.532) 0.694 -3.461(5.466) 0.527 -4.112(5.538) 0.458 
RBANS Index V                      R2=0.127                  R2=0.128                     R2=0.127          R2=0.124 
BMI 0.107(0.080) 0.183 0.100(0.081) 0.220 0.105(0.080) 0.190 0.079(0.082) 0.340 
WHR -21.280(5.483) <0.001 -21.243(5.549) <0.001 -21.278(5.484) <0.001 -20.640(5.587) <0.001 
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RBANS Total Scale                     R2=0.260                  R2=0.260                     R2=0.260          R2=0.258 
BMI 0.076(0.065) 0.241 0.084(0.066) 0.200 0.074(0.065) 0.252 0.063(0.066) 0.342 
WHR -18.390(4.437) <0.001 -17.546(4.498) <0.001 -18.394(4.437) <0.001 -18.048(4.505) <0.001 
MMSE                      R2=0.125                  R2=0.126                     R2=0.125                     R2=0.124 
BMI -0.001(0.007) 0.929 -0.001(0.007) 0.938 -0.001(0.007) 0.912 -0.002(0.007) 0.730 
WHR -1.457(0.480) 0.002 -1.442(0.486) 0.003 -1.457(0.480) 0.002 -1.397(0.486) 0.004 
FAB(log)                      R2=0.125                  R2=0.126                     R2=0.126                      R2=0.125 
BMI -0.001(0.001) 0.403 -0.001(0.001) 0.281 -0.001(0.001) 0.420 -0.001(0.001) 0.524 
WHR 0.221(0.090) 0.014 0.200(0.091) 0.028 0.221(0.090) 0.014 0.198(0.091) 0.030 
 
 
Model 1: Age, Education (Duration schooling), Sex (male), BMI, WHR, Current smoker, Past smoker, TUG, Total IADL 
Model 2: Model 1 + Haemoglobin A1C (HbA1C) 
Model 3: Model 1 + cerebrovascular diseases(transient ischaemic attack and/or stroke) 
Model 4: Model 1 + c-reactive protein (CRP) 
 
Abbreviations: BMI-Body Mass Index, WHR- Waist-Hip Ratio, TUG- Timed-Up-and-Go, IADL- Instrumental Activities of Daily Living, 
MMSE-Mini-Mental State Examination, FAB-Frontal Assessment Battery, RBANS-Repeatable Battery for the Assessment of 
Neuropsychological Status 
 
 
 
 
 
 
 
 
 
 
 
 
 
